Years of work developing new treatments at Lundbeck has so far come to nothing. This has led chairman Lars Rasmusssen to demand visible results, even though CEO Deborah Dunsire has essentially had to restart development work since she joined the firm in 2018.
The Polish Ministry of Health has increased the reimbursement amount for hydrophilic catheters, which Coloplast supplies. The Danish medtech company calls the new scheme a "breakthrough."
.jpg)
An analyst at Sydbank thinks that Eli Lilly's third quarter report includes a number of positive elements, and emphasizes that this could also be good news for competitor Novo Nordisk.
On Tuesday, US-based pharmaceutical firm Eli Lilly has updated elements of its 2021 financial guidance pertaining to earnings per share (non-GAAP), now expecting USD 7.95-8.05 compared to the previous USD 7.8-8.
Integrating cloud solutions has helped with Novo Nordisk's sustainable transition, Danish media reports.
Core earnings per share ended the period at a higher level than analysts' estimates for Novartis's Q3.
Genmab may upgrade its financial guidance after the biotech company's partner made more sales than expected of sclerosis drug Kesimpta, a Sydbank analyst predicts.
The negative developments in Q3 have caused Össur to downgrade its full year guidance to the lower boundary of its previous guidance interval.
US-based pharmaceutical firm MSD has allowed its drug Keytruda to be used for a phase IIb trial conducted by Evaxion. The Danish biotech company will test its own lead candidate against melanoma in combination with MSD's multi-blockbuster drug.
The nitric acid leak at a Novo Nordisk facility in the Danish town of Hillerød has been dealt with, and employees have returned to the building in question, the company informs MedWatch, reporting that the leak hasn't affected production.
The drug Adtralza, which is developed by Leo Pharma, has reached both its primary and secondary endpoints after a 16-week phase III trial testing the eczema treatment in patients with moderate-to-severe atopic dermatitis.
A tender has been initiated by the Danish regions to acquire ultrasound scanners for six different medical disciplines. The tender could reach a value of nearly DKK 1bn (USD 156.5m).
Biotech company Union Therapeutics is testing its candidate niclosamid as a nasal spray for patients infected with Covid-19 who are either asymptomatic or mildly symptomatic in a phase II study.
Common infections may have been the reason that a number of adolescents experienced symptoms after receiving the HPV vaccination, a new study conducted by Aarhus University suggests.
Unlike many large pharmaceutical companies, Sandoz is still investing in antibiotics, most recently through the acquisition of a GSK portfolio and an expansion in European production. This business area will remain central to the company, says Carol Lynch.
A letter from Leo Pharma to the agency reveals that the pharmaceutical company is not satisfied with the Danish Medicines Council's assessment of eczema treatment Adtralza.
No injuries have been reported after a nitric acid leak at a Novo Nordisk facility in the Danish town of Hillerød. Police have closed roads in the area while the leak is contained.
Eli Lilly is experiencing judicial headwind in the US, as a federal court has ordered the Novo Nordisk competitor to pay royalities from insulin sales to an Arizonan firm.
Miss anything?
Both primary and secondary endpoints were met in a new phase III trial of Sanofi's bestseller drug Dupixent, this time as a treatment for the rare skin disease prurigo nodularis.
Deepa Prasad joins Vtv Therapeutics from Westriver Group, replacing the former the president and CEO, who has overseen the development of oral drugs for diabetes and psoriasis.
Now is the time to invest in healthcare, says Sofinnova Partners, as it announces a new fund to back life science startups.
Hearing device manufacturer Audientes sees a golden opportunity on the US hearing aid market, and with the release of Tuesday's FDA proposal for the guidelines of the upcoming over-the-counter sales channel, the company has taken its plans for hearing device "Ven" up a gear.
GN Hearing and Demant both gained ground on the lucrative hearing aid sales channel for American veterans in September.
After a short dialog with the authorities and its partner, Sage, Biogen is planning to start the application process for marketing authorization for its depression drug zuranolone in 2022. This is despite the fact that a recent study did not generate overwhelmingly convincing results.
KLIFO is looking for a talented and committed Pharmacovigilance Associate based in Denmark 
Senior Director, Global Regulatory Lead VP, Head of CMC Pharmaceutical and Device Development 
Chemist for Late Stage Analytical Development (1-year temporary position) 
Director of Biostatistics 
Senior Legal Advisor 
Software Developer, Cardiac Applications – Medical Devices, DK Senior Clinical Project Manager Senior Manager Pharmaceutical Development and Manufacturing SAP Process Supporter for Operations at ALK 
CMC Product Support Manager 
Head of Engineering, Syntese 
Clinical Documentation Specialist Training manager Laboratory assistant for research department 
Principal Statistician / Statistical Project Director 
Associate Director – MedTech Manufacturing Cleaning chemist 
Global Product Manager Data Analytics & Visualization Manager Senior Manager/Associate Director Regulatory Affairs Jr. Software Developer, Cardiac Applications – Medical Devices, DK Senior Programmer at Genmab 
GxP QA Compliance Manager for Quality Assurance 
Key Account Manager – Lab & Diagnostic 
